More Ways to Connect
  Facebook Twitter YouTube
  RSS LinkedIn PInterest
Search
Find a Clinical Trial

Participation in a Clinical Trial 
The involvement of the University of Cincinnati and its physician practice, UC Physicians, in research studies is crucial to understanding diseases and developing new ways to understand, prevent or treat health problems.

Research studies, or trials as they are often called, depend on volunteers who agree to be part of carefully controlled tests that measure the effects of medications, medical treatments or devices. By volunteering, you can further medical knowledge and potentially help others.

UC Physicians’ mission is to be a leader in improving health. As part of that mission, doctors and scientists at the University of Cincinnati Academic Health Center conduct research that improves the quality of care in the community, the nation and the world.

Want More Information?
Learn more about clinical studies, including the protections that are in place to keep you safe.

Additional clinical trials opportunities can be found at ResearchMatch, a registry created through a large network of major academic institutions – including the University of Cincinnati – funded by the National Center for Research Resources, a component of the National Institutes of Health. ResearchMatch will help match any type of approved study that is looking for people to participate in their study. You may be contacted about different research opportunities ranging from a survey you can do at home to a clinical trial that may involve you traveling to the researcher’s institution. 

View a video and read a story about understanding clinical trials and what they mean for cancer patients.


The following is a list of recent government-based clinical trials taking place at the UC Academic Health Center. This information is obtained from www.clinicaltrials.gov. Please note that this is not an all-inclusive list. If you have any questions or would like to receive additional information about current and upcoming clinical trials, please contact UC Health Clinical Trials Office at  (513) 475-8031 or clinicaltrials@ucphysicians.com.


Sort By:    Post Date     Condition   
Search For:  
(Advanced) Coronary Heart Disease
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
01/10/12 — Conditions: (Advanced) Coronary Heart Disease, Chronic Myocardial Ischemia, Refractory Angina Pectoris
Acute Decompensated Heart Failure
Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics
10/19/11 — Conditions: Acute Decompensated Heart Failure
REducing 30-day ADMIssions in posT-discharge Subjects
04/03/12 — Conditions: Acute Decompensated Heart Failure
Acute Decompensated Heart Failure (ADHF)
Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
11/11/11 — Conditions: Acute Decompensated Heart Failure (ADHF), Cardiac Failure, Heart Failure
Acute Ischemic Stroke
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
06/06/11 — Conditions: Acute Ischemic Stroke, Diabetes, Hyperglycemia
Acute Liver Failure
A Multi-Center Group to Study Acute Liver Failure in Children
09/29/09 — Conditions: Acute Liver Failure, Hepatic Encephalopathy
Acute Lung Injury
Mechanical Ventilation in the Emergency Department: A Prospective Cross-Sectional Study
06/20/12 — Conditions: Acute Lung Injury, Mechanical Ventilation, Respiratory Failure
acute lymphoblastic leukemia, leukemia, ALL, phase III, phase 3, blood cancer
An Open-label Randomized Phase 3 Study of Inotuzumab Ozogamicin Compared to a Defined Investigator’s Choice in Adult Patients with Relapsed or Refractory CD22-Positive Acute Lymphoblastic Leukemia (ALL)
06/07/13 — Conditions: acute lymphoblastic leukemia, leukemia, ALL, phase III, phase 3, blood cancer
Adenocarcinoma of the Esophagus
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
09/04/10 — Conditions: Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
Adenocarcinoma of the Gastroesophageal Junction
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
09/04/10 — Conditions: Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer

 1-10 out of 495